Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Factor XIII Val34Leu polymorphism and the risk of myocardial infarction under the age of 36 years.

Thrombosis and haemostasis - 1 Jun 2008

Rallidis Loukianos S, Politou Marianna, Komporozos Christoforos, Panagiotakos Demosthenes B, Belessi Chrisoula I, Travlou Anthi, Lekakis John, Kremastinos Dimitrios T

Abstract excerpt

There are limited and controversial data regarding the impact of factor XIII (FXIII) Val34Leu polymorphism in the pathogenesis of premature myocardial infarction (MI). We examined whether FXIII Val34Leu polymorphism is associated with the development of early MI. We recruited 159 consecutive patients who had survived their first acute MI under the age of 36 years (mean age = 32.1 +/- 3.6 years, 138 were men). The...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Age Factors
Share to Age of Onset

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Coronary Disease

Share to Factor XIII

Share to Greece

Share to Myocardial Infarction

Share to Odds Ratio

Share to Risk Assessment

Source

Identifiers

PMID: 18521512
DOI: 10.1160/TH07-12-0755

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Factor XIII Val34Leu polymorphism and the risk of myocardial infarction under the age of 36 years.PMID 18521512Read ↗

Coagulation factor XIII-A Val34Leu polymorphism and the risk of coronary artery disease and myocardial infarction in a Chinese Han population.Semantic proximity Read ↗

The association between factor XIII Val34Leu polymorphism and early myocardial infarction.Semantic proximity Read ↗

Effect of factor XIII-A Val34Leu polymorphism on myocardial infarction risk: a meta-analysis.Semantic proximity Read ↗

Factor XIII val34leu and the risk of myocardial infarction.Semantic proximity Read ↗

Role of factor XIII Val34Leu polymorphism in patients <45 years of age with acute myocardial infarction.Semantic proximity Read ↗

A pharmacogenetic effect of factor XIII valine 34 leucine polymorphism on fibrinolytic therapy for acute myocardial infarction.Semantic proximity Read ↗

Factor XIII Val34Leu variant protects against coronary artery disease. A meta-analysis.Semantic proximity Read ↗

Association of FXIII Val34Leu with decreased risk of myocardial infarction in Finnish males.Semantic proximity Read ↗

Factor XIII Val34Leu variant and the risk of myocardial infarction: a meta-analysis.Semantic proximity Read ↗

Factor XIII Val34Leu variant protects against coronary artery diseaseSemantic proximity Read ↗

Factor XIII-A subunit Val34Leu polymorphism in fatal atherothrombotic ischemic stroke.Semantic proximity Read ↗

Association of factor XIII Val34Leu polymorphism and coronary artery disease: A meta-analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.